Adult consulting:
mon-fr: 8:30-15:30

Children consulting:
mon-fr: 8:30-15:30

of children

5 A, Bratyslavska str,
Kyiv 02166, Ukraine

Conference “Venous thromboembolism: new approaches to diagnosis and treatment”

October 6, 2016 at the Heart Institute of MOH of Ukraine the conference “Venous thromboembolism: new approaches to diagnosis and treatment” was held, in which the staff and students of the departments of cardiac surgery, endovascular and extracorporeal technologies and functional diagnostics actively participated. The idea of the conference was to discuss the main premises of current guidelines for the diagnosis and treatment of venous thrombosis, pulmonary embolism, as well as the universal protocol to help patients with pulmonary hypertension, as approved by the Ministry of Healthcare of Ukraine.

Head of the Department of Cardiac Surgery, endovascular and extracorporeal techniques, corresponding member of the NAMS of Ukraine, Professor Boris Todurov in his report dwelled on the surgical aspects of treatment of pulmonary embolism.

A report on the endovascular diagnosis of pulmonary embolism was made by the head of the department of endovascular surgery and angiography A.V. Khokhlov.

Associate Professor of the Department of functional diagnostics L.A. Tkachenko covered modern approaches to the management of patients with posttromboembolitic pulmonary hypertension. Head of the Chair Professor of functional diagnostics O.I. Zharinov dwelled on the aspects of prevention of thrombotic complications in patients with heart failure.

The conference gathered the leading experts on the problem of venous thrombosis Professor L.M. Chernukha (National Institute of Surgery and Transplantation named after A.A. Shalimov) and Senior Researcher Y.M. Lutai (Institute of Cardiology named after Strazhesko ).

The particular interest of the audience was drawn by a report of invited guest – Professor Jeffrey Anderson (University of Utah, Salt Lake City, USA), who compared the advantages and disadvantages of modern direct oral anticoagulants.

The conference was attended by 140 doctors of various specialties, mainly cardiologists.


Right Menu Icon